Pfizer, IBM and Microsoft have launched Amicore, an independent softwareand services company aimed at reducing "the administrative workload and paperwork for physicians, allowing them to dedicate more time toward their mission of providing quality patient care." Amicore also announced the acquisition of PenChart Corp, a Connecticut, USA-based health care application developer, to form the core of the company's initial product offering and accelerate its product development strategy.
Pfizer, which joined forces with IBM and Microsoft earlier this year (Marketletter April 9), says that a recent customer study showed that PenChart software "almost entirely eliminated the cost of filing and retrieving paper medical records and reduced the cost of ordering prescription refills and of transcription services by over 80%."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze